Trial intelligence / Profile preview

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

NCT03232554Phase 2Unknown

Sponsor
Peking Union Medical College Hospital
Start
Jun 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of buxue yimu wan in iron deficiency anemia (IDA) (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Complete Blood Count at 4 weeks. Status: unknown.

02

Drugs

buxue yimu wan
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT03232554.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03232554.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call